Spruce Street Capital »

Minerva Neurosciences shares owned by Spruce Street Capital

Quarter-by-quarter ownership of Minerva Neurosciences (NERV) shares owned by Spruce Street Capital from 13F filings

Historical chart of Spruce Street Capital investment in Minerva Neurosciences

Tip: Access up to 7 years of quarterly data

All positions including Minerva Neurosciences held by Spruce Street Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Minerva Neurosciences by Spruce Street Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.2M 1.7M 5.55

More positions owned by Spruce Street Capital

Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Relay Therapeutics (RLAY)
Lb Pharmaceuticals Com Shs (LBRX)
Relmada Therapeutics (RLMD)
Alto Neuroscience Com Shs (ANRO)
Dianthus Therapeutics (DNTH)
Alkermes SHS (ALKS)
Savara (SVRA)
Vaxcyte (PCVX)
Enliven Therapeutics (ELVN)
Enanta Pharmaceuticals (ENTA)
Perspective Therapeutics Com New (CATX)
Inflarx Nv (IFRX)
Surrozen Com New (SRZN)
Alumis (ALMS)

View all positions for Spruce Street Capital

Top funds holding Minerva Neurosciences

Federated Investors
Vivo Capital
Henderson Group
Balyasny Asset Management
Logos Global Management
Farallon Capital Management
Foresite Capital Management VI
Vanguard Capital Management
Spruce Street Capital
Ally Bridge Group
Adage Capital Partners GP
Trails Edge Capital Partners
Longwood Capital Partners
Millennium Management
BlackRock

View all funds holding Minerva Neurosciences